Literatur
Verwendete Literatur
Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393(10167):169–182
Robert Koch-Institut (2017) Krebs in Deutschland 2013/2014. Robert Koch-Institut, Berlin
Schneede P (2017) One decade of HPV vaccination in Germany. Urologe A 56(6):728–733
Landoni F, Bocciolone L, Perego P, Maneo A, Bratina G, Mangioni C (1995) Cancer of the cervix, FIGO stages IB and IIA: patterns of local growth and paracervical extension. Int J Gynecol Cancer 5(5):329–334
Höckel M, Wolf B, Schmidt K et al (2019) Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study. Lancet Oncol 20(9):1316–1326
AWMF. Leitlinienprogramm Onkologie (2014) S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom, Langversion, 1.0 (AWMF-Registernummer: 032/033OL)
Wolpert L (1969) Positional information and the spatial pattern of cellular differentiation. J Theor Biol 25(1):1–47
Dahmann C, Oates AC, Brand M (2011) Boundary formation and maintenance in tissue development. Nat Rev Genet 12(1):43–55
Hockel M, Horn LC (2013) The puzzle of close surgical margins is not puzzling. Gynecol Oncol 130(1):224–225
Höckel M (2015) Morphogenetic fields of embryonic development in locoregional cancer spread. Lancet Oncol 16(3):e148–51
Höckel M, Hentschel B, Horn LC (2014) Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol 15(4):445–456
Höckel M, Trott S, Dornhofer N, Horn LC, Hentschel B, Wolf B (2018) Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial. Lancet Oncol 19(4):537–548
Yang Y, Oliver G (2014) Development of the mammalian lymphatic vasculature. J Clin Invest 124(3):888–897
Höckel M (2001) Total mesometrial resection: nerve-sparing extended radical abdominal hysterectomy. Zentralbl Gynakol 123(5):245–249
Cibula D, Abu-Rustum NR, Benedetti-Panici P et al (2011) New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. Gynecol Oncol 122(2):264–268
Landoni F, Maneo A, Cormio G et al (2001) Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol 80(1):3–12
Landoni F, Maneo A, Colombo A et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350(9077):535–540
Ramirez PT, Frumovitz M, Pareja R et al (2018) Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 379(20):1895–1904
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst 85(5):365–376
Baessler K, Kempkensteffen C (2009) Validation of a comprehensive pelvic floor questionnaire for the hospital, private practice and research. Gynakol Geburtshilfliche Rundsch 49(4):299–307
Thirlaway K, Fallowfield L, Cuzick J (1996) The sexual activity questionnaire: a measure of women’s sexual functioning. Qual Life Res 5(1):81–90
Buderath P, Stukan M, Ruhwedel W, Strutas D, Feisel-Schwickardi G, Wimberger P, Kimmig R (2021) Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study. J Gynecol Oncol 33:e9. https://doi.org/10.3802/jgo.2022.33.e9
Weiterführende Literatur
Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P (2020) Cervical cancer: 2018 revised international federation of gynecology and obstetrics staging system and the role of imaging. AJR Am J Roentgenol 214(5):1182–1195
Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol 73(2):177–183
Cibula D, Abu-Rustum NR, Fischerova D et al (2018) Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—a retrospective cohort study and review of the literature. Gynecol Oncol 151(3):438–443
Mangler M, Zech N, Schneider A, Kohler C, Marnitz S (2013) Aspects of therapy for cervical cancer in Germany 2012—results from a survey of German gynaecological hospitals. Geburtshilfe Frauenheilkd 73(3):227–238
Nasser S, Almuheimid J, Plett H, Sehouli J, Muallem MZ (2016) Feasibility and safety of laparoscopic total mesometrial resection in early-stage cervical cancer. Anticancer Res 36(9):4903–4907
Chiantera V, Vizzielli G, Lucidi A et al (2015) Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): a multicentric experience. Gynecol Oncol 139(1):47–51
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143(2):22–36
Wenzel HHB, Kruitwagen R, Nijman HW et al (2020) Short-term surgical complications after radical hysterectomy—a nationwide cohort study. Acta Obstet Gynecol Scand 99(7):925–932
Plotti F, Terranova C, Capriglione S et al (2018) Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors. Int J Gynecol Cancer 28(4):818–823
Sowa E, Kuhnt S, Hinz A, Schroder C, Deutsch T, Geue K (2014) Postoperative health-related quality of life of cervical cancer patients—a comparison between the Wertheim-Meigs operation and total mesometrial resection (TMMR). Geburtshilfe Frauenheilkd 74(7):670–676
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Buderath und R. Kimmig geben an, dass kein Interessenkonflikt besteht.
Die Studie wurde von der lokalen Ethikkommission in Essen genehmigt (Ethikvotum Nr. 12-5190 BO).
Additional information
Redaktion
Tanja Fehm, Düsseldorf
Ludwig Kiesel, Münster
Rainer Kimmig, Essen
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Buderath, P., Kimmig, R. Totale mesometriale Resektion (TMMR) + therapeutische Lymphonodektomie (tLNE) beim Zervixkarzinom FIGO IB – IIAIIA. Gynäkologe 55, 114–121 (2022). https://doi.org/10.1007/s00129-021-04899-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-021-04899-x